Johnson & Johnson, the US pharmaceuticals group, has a month to decide whether to try to claim back full rights over two pivotal medicines as a result of Merck’s US$41 billion planned takeover of Schering-Plough according to Financial Times.
All takeover news could have far-reaching implications for©the company’s©animal health divisions. Schering-Plough is the holding company of Intervet/Schering-Plough Animal Health. This animal health company was created after a takeover of Akzo Nobel’s health division Organon by Schering-Plough©in 2007. Belgian pharmaceutical company Janssen Animal Health is a subsidiary of©Johnson & Johnson.
Only two months ago, US pharmaceutical company Pfizer announced to purchase American animal health company Wyeth, which includes Fort Dodge Animal Health.
Related news item:
Merck and Schering-Plough announce merger©(March 11, 2009)©